Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
2013
The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus
2009
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
2007 Standout
Acute kidney injury
2012 Standout
Uromodulin: from physiology to rare and complex kidney disorders
2017
Diabetic retinopathy
2010 Standout
Revisiting the glomerular charge barrier in the molecular era
2008
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable Troponin Using a High-Sensitivity Assay
2011
Antithrombotic Therapy for VTE Disease
2016 Standout
Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men
2002
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
2008
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Psoriasis
2021 Standout
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
2004
Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control
1992
Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002
2008
Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective
2012
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Management of Diabetic Retinopathy
2007
Chronic kidney disease
2011 Standout
Biologic markers for the early detection of acute kidney injury
2004
New Equations to Estimate GFR in Children with CKD
2009 Standout
Prospective Association between Diabetic Retinopathy and Cardiovascular Disease—A Systematic Review and Meta-analysis of Cohort Studies
2016
Antithrombotic Therapy for VTE Disease
2012 Standout
Diabetic Retinopathy
2012 Standout
Screening for Proteinuria in US Adults
2003
Diabetic retinopathy and systemic vascular complications
2007
Early prediction and prevention of pre-eclampsia
2011
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Stretch-induced Retinal Vascular Endothelial Growth Factor Expression Is Mediated by Phosphatidylinositol 3-Kinase and Protein Kinase C (PKC)-ζ but Not by Stretch-induced ERK1/2, Akt, Ras, or Classical/Novel PKC Pathways
2002
Cardiorenal Syndrome
2008 Standout
Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I
2005
Pathophysiology of proteinuria
2003
Dynamics and functions of lipid droplets
2018 Standout
Excess type 2 diabetes in African-American women and men aged 40–74 and socioeconomic status: evidence from the Third National Health and Nutrition Examination Survey
2000
Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability
2005
Chronic kidney disease: global dimension and perspectives
2013 Standout
Type 1 diabetes
2013 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice
2005
Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy
2003
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
2007
Home Therapy of Venous Thrombosis with Long-term LMWH versus Usual Care: Patient Satisfaction and Post-thrombotic Syndrome
2009
Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study
2008
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
2005
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Uromodulin in Kidney Injury: An Instigator, Bystander, or Protector?
2012
Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator–Activated Receptor-γ Agonist
2006
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH
2022 StandoutNobel
PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
2010
Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic
2013
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
Chronic Kidney Disease
2016 Standout
Pre-eclampsia
2015 Standout
A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome
2000
Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults
2015
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
Early detection of acute renal failure by serum cystatin C
2004
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes
2006
Coronary Artery Disease in IDDM
1996
Urinary Albumin Excretion
1999
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Advanced Glycation End Products
2006 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
2001 Standout
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Global Disparities of Hypertension Prevalence and Control
2016 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Combination therapy with GLP ‐1 receptor agonists and basal insulin: a systematic review of the literature
2012
The extracellular matrix at a glance
2010 Standout
Mechanisms of Tubulointerstitial Injury in the Kidney: Final Common Pathways to End-stage Renal Failure
2004
Diabetic Kidney Disease
2017 Standout
Type 1 Diabetes and Coronary Artery Disease
2006
The effect of addition of liraglutide to high‐dose intensive insulin therapy: a randomized prospective trial
2014
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
2014
Mechanisms of Diabetic Complications
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor—2
2001
Urinary Albumin Excretion and History of Acute Myocardial Infarction in a Cross-Sectional Population Study of 2613 Individuals
1997
Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic
2019
Circadian variability of blood pressure in obese children
2007
Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2017
Diagnostic Performance of Random Urine Samples Using Albumin Concentration vs Ratio of Albumin to Creatinine for Microalbuminuria Screening in Patients With Diabetes Mellitus
2014
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Ole Torffvit being referenced
The prevalence of retinopathy and associated medical risk factors in type I (insulin‐dependent) diabetes mellitus
1989
Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study
2002
Urinary Excretion of Tamm-Horsfall Protein and Epidermal Growth Factor in Chronic Nephropathy
1998
Putative Risk Factors Associated with Retinopathy in Patients with Diabetes Diagnosed at or after 30 Years of Age
1989
Metabolic status in diabetes mellitus affects markers for glomerular filtration rate
2003
Urinary Excretion of Tamm-Horsfall Protein in Normotensive, Normo-Albuminuric Type 1 Diabetic Patients
1996
Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy
2002
Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy
2002
High proteinuria selectivity index based upon IgM is a strong predictor of poor renal survival in glomerular diseases
2001
A Four‐year Follow‐up Study on the Incidence of Diabetic Retinopathy in Older Onset Diabetes Mellitus
1994
The prognosis for Type 2 diabetic patients with heart disease
2000
The predictive value of albuminuria for cardiovascular and renal disease
1993
Diagnostic and prognostic significance of proteinuria selectivity index in glomerular diseases
2000
Diabetic retinopathy, visual acuity, and medical risk indicators. A continuous 10-year follow-up study in Type 1 diabetic patients under routine care
2001
The prognostic value of albuminuria for the development of cardiovascular disease and retinopathy: a 5-year follow-up of 451 patients with type 2 diabetes mellitus
1996
The impact of metabolic and blood pressure control on incidence and progression of nephropathy
2001
Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis
2006
Size and charge selectivity of the glomerular filter in early experimental diabetes in rats
2007
Urinary Excretion Rate of Tamm-Horsfall Protein Is Related to Salt Intake in Humans
2004
Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy
1993
Urinary excretion of epidermal growth factor and Tamm–Horsfall protein in three rat models with increased renal excretion of urine
1997
Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12‐year observation study of 462 patients
2005
Size and Charge Selectivity of the Glomerular Filter in Patients with Insulin-Dependent Diabetes mellitus: Urinary Immunoglobulins and Glycosaminoglycans
1999
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
2015
Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient
1994
Increased tubuloglomerular feedback reactivity is associated with increased NO production in the streptozotocin-diabetic rat
2000
Proteinuria selectivity index based upon α2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases
1998
Increased glomerular albumin permeability in old spontaneously hypertensive rats
2004
The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care
1997
Type 1 diabetes patients with severe non‐proliferative retinopathy may benefit from panretinal photocoagulation
2003
Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion
1995
Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction
2011
Tubular Secretion of Tamm-Horsfall Protein Is Decreased in Type 1 (Insulin-Dependent) Diabetic Patients with Diabetic Nephropathy
1993
A Study of Tamm-Horsfall Protein Excretion in Hypertensive Patients and Type 1 Diabetic Patients
1999
Effect of Insulin on Systemic and Renal Handling of Albumin in Nondiabetic and NIDDM Subjects
1997
Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease
2003
Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management
2003
Renal structures in type 2 diabetic patients with elevated albumin excretion rate
2001
Occurrence of Autoqntibodies Directed Against Myeloperoxidase and Elastase in Patients Treated with Hydralazine and Presenting with Glomerulonephritis
1994
Decreased urinary concentration of Tamm–Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients
2008